Bids Are Invited For Price Registration For Future Drug Acquisition, To Meet The Demands Of The Antonio Martins Da Costa Municipal Hospital And The Citizen Pharmacy (Work Plans No. 202400010005236, No. 202400010005282, No. 202400010005284, No. 2025005012929, No. 202500005012928, No. 202500042006680), Under The Supervision Of The Municipal Health Fund Of Quirinópolis-Go, According To Specifications And Quantities Established In Dfd, Etp And Term Of Reference, Annexes In This Process.

Acebrophylline, Dosage/Concentration: 10 Mg/Ml, Pharmaceutical Form: Syrup 120Ml (Br0448839), Dosage/Concentration: 5 Mg/Ml, Pharmaceutical Form: Syrup 120Ml (Br0448838), Tranexamic Acid, Dosage/Concentration: 50 Mg/Ml, Ampoule Injectable Solution 5Ml (Br0327566), Distilled Water, Physical Aspect: Bidestilated, Sterile, Apirogenic, 10Ml Ampoule (Br0315056), Acetylsalicylic Acid, Dosage/Concentration: 100 Mg (Br0267502), 11/09/2025, Ascorbic Acid, Dosage/Concentration: 100 Mg/Ml, Type Ampoule 5Ml (Br0271687), Épsilon-Amaminocaproic Acid, Dosage/Concentration: 500Mg, Human Albumin, Use: Injectable, Dosage/Concentration: 20% Vial 50Ml (Br0268376), Alteplase, Dosage/Concentration: 50 Mg, Liophile Powder P/Injectable + Diluent (Br0436418), Ambroxol, Composition: Salt Hydrochloride, Dosage/Concentration: 6 Mg/Ml, Pharmaceutical Form: Syrup 120Ml (Br0446263), Amoxicillin, Dosage/Concentration: 500Mg (Br0271089), Dosage/Concentration: 875Mg + 125Mg, Active Ingredient (Br0353333), Amphotericin B, Dosage/Concentration: 100 Mg, Pharmaceutical Form: Liophile Powder For Injectable, Additional Characteristics: Liposomal (Br0276823), Dosage/Concentration: 20 Mg/Ml, Pharmaceutical Form: Oral Suspension - Drops 30Ml (Br0476830) Atomoxetine Hydrochloride, Oral Use, Dosage/Concentration: 10Mg, Axethylcefuroxima, Dosage/Concentration: 500Mg, Azithromycin, Dosage/Concentration: 500 Mg (Br0267140), Beclomethasone Dipropionate Of Oral Aerosol, Dosage/Concentration: 50Mcg, Accompanied By Inhaler (Device For Unaltation L -Shaped Oral), 200 Doses, Benzilpenyicillin, Dosage/Concentration: 1.200.000Ui, Presentation: Benzatin (Br0270612), Dosage/Concentration: 600.000Ui, Presentation: Benzatin, Bisoprolol Fumarate, Dosage/Concentration: 1, 25 Mg (Br0362719), Dosage/Concentration: 2, 5 Mg (Br0362720), Bromopride, Presentation: Injectable Ampoule 2Ml (Br0269958), Bupropion Hydrochloride, Dosage/Concentration: 150 Mg, Additional Characteristics: Prolonged Release (Br0460986), Captopril, Dosage/Concentration: 25 Mg (Br0267613) Dosage/Concentration: 500 Mg (Br0267625), Ceftriaxone, Dosage/Concentration: 1 G, Pharmaceutical Form: Powder For Injectable Solution (Br0442701), Celecoxib, Dosage/Concentration: 200 Mg (Br0268866), Ketoprofen, Pharmaceutical Form: Pharmaceutical Powder P/Injectable (Br0448844), Cyproterone Acetate, Dosage/Concentration: 2Mg + 0, 035Mg, Associated With Ethinilelestradiol (Br0271089), Clarithromycin, Dosage/Concentration: 500 Mg, Presentation: Injectable (Br0268440), Presentation: Slow Release (Br0269985), Clonidine) Hydrochloride, Dosage/Concentration: 0, 1 Mg (Br0272043), 15 Mg (Br0272044), 15 Mg/Ml, Pharmaceutical Form: Injectable Solution Ampoule 2Ml (Br0340206), Clopidogrel, Dosage/Concentration: 75 Mg, Chlorhexidine Diglucanato, Dosage: 2%, Application: Application: Application: Degermante 100Ml Bottle, Application: Degerman, 1Liter Bottle (Br0269876), Colchicine, 5 Mg (Br0267642), Colecalciferol, Dosage/Concentration: 3,300 Ui/Ml, Pharmaceutical Form: Oral Solution-Got Vasch 30Ml (Br0391938), Dishonestrel, Dosage/Concentration: 75 Mcg (Br0356701), Devenlafaxine, Succinate Salt, Controlled Release (Br0405898), Dexamethasone, Dosage/Concentration: 4 Mg/Ml, Pharmaceutical Form: Injectable Solution With 2, 5Ml, Dexclorphenide Maleate, 4 Mg/Ml, Presentation: Oral Solution 120Ml (Br0267646), Dosage/Concentration: 2 Mg (Br0267645), Diclofenac, Use: Injectable Solution, Dosage/Concentration: 25Mg

17,51,090 - BRL

FileName	File Description
Global Tender Document	Tender Notice